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ABSTRACT
Trichosanthes dioica Roxb. (Cucurbitaceae), called pointed gourd in English, is a dioecious climber grown widely in the Indian sub-
continent. The present study assessed the influence of treatment of hydroalcoholic extract of Trichosanthes dioica root (TDA) on 
Ehrlich ascites carcinoma (EAC) in Swiss albino mice with effects on antioxidant systems. Twenty-four hours after intraperitoneal 
inoculation of tumor (EAC) cells in mice, TDA was administered at 25 and 50 mg/kg for 8 consecutive days. On the 9th day, half of 
the mice were sacrificed for estimation of tumor proliferation, hematological, and hepatic antioxidative parameters. The rest were 
kept for assessment of survival parameters. TDA exhibited dose dependent and significant increase in tumor weight, tumor volume, 
packed cell volume and viable cells and reduced non-viable cells and life span of EAC bearing animals. Hematological parameters 
were significantly worsened in TDA-treated mice. TDA treatment significantly aggravated the hepatic antioxidative parameters. The 
present study demonstrated that T. dioica root possessed tumor promoting activity in EAC bearing albino mice, plausibly mediated 
by attenuation of endogenous antioxidant systems. 
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originally as a spontaneous murine mammary adenocar-
cinoma. It grows in both solid and ascitic forms. It is a 
rapidly growing carcinoma with very aggressive behavior 
and is able to grow in almost all strains of mice. In ascitic 
form, it has been used as a transplantable murine tumor 
model to investigate the tumorigenic and antitumor 
effects of several natural and synthetic chemical sub-
stances showing precise and reproducible results (Chen & 
Watkins, 1970; Segura et al., 2000).
Trichosanthes dioica Roxb. (Cucurbitaceae), called 
pointed gourd in English, Potol in Bengali and Patola in 
Sanskrit, is a dioecious climber found wild throughout 
the plains of North and North-East India from Punjab to 
Assam and Tripura states of India. It is also grown and 
commercially cultivated in India, Pakistan, Bangladesh 
and Sri Lanka for its fruits, a common culinary vegetable 
in the Indian subcontinent. In India, all parts of this 
plant have been traditionally used for various medicinal 
purposes. According to Ayurveda, the traditional system 
of Indian medicine, its root is a strong purgative. The 
root has been traditionally used in India as purgative and 
Introduction
Plants have a long history of use in the treatment of can-
cer. The approach for minimizing unwanted toxicity is to 
employ newer natural products that may act by different 
and distinct mechanism(s) and/or precipitate less serious 
side effects. A number of plant or other natural products 
have been studied for anticancer activity leading to the 
development of several clinically useful anticancer agents 
(da-Rocha et al., 2001). However, certain plant products 
demonstrate mutagenic, pro-carcinogenic or tumor pro-
moting effects when administered to normal or tumor 
bearing animals.
The Ehrlich ascites carcinoma is a transplantable, 
poorly differentiated, malignant tumor which appeared 
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as tonic, febrifuge, in treatment of jaundice, anasarca 
and ascites (Kirtikar & Basu, 1935; Anonymous, 1976; 
Nadkarni, 1976; Sharma et al., 2002). In our earlier stud-
ies, we reported antihelmintic effects of leaf and root, 
antibacterial and antimitotic activities of the root of T. 
dioica. (Bhattacharya et al., 2009, 2010; Bhattacharya & 
Haldar, 2010a,b). The present study examined the influ-
ence of treatment with hydroalcoholic extract of T. dioica 
root on Ehrlich ascites carcinoma (EAC) growth in Swiss 
albino mice with effects on antioxidant systems in vivo. 
Materials and methods
Plant material
The mature tuberous roots of T. dioica were collected 
during December 2008 from Majdia, Nadia district, West 
Bengal, India. The species was identified by Dr. M. S. 
Mondal, at the Central National Herbarium, Botanical 
Survey of India, Howrah, West Bengal, India, and a 
voucher specimen (CNH/I-I/57/2009/Tech.II/493) was 
deposited at Pharmacognosy Research Laboratory, Bengal 
School of Technology, Delhi Road, Hooghly 712102, 
India. Just after collection, the plant material was washed 
thoroughly with running tap water, shade dried at room 
temperature (24–26 °C) and ground mechanically into a 
coarse powder.
Drugs and chemicals
Bovine serum albumin from Sigma Chemical Co., 
St. Louis, Mo, USA;  trichloroacetic acid (TCA) and 
1-dichloro-2,4-dinitrobenezene (CDNB) from Merck 
Ltd., Mumbai, India; thiobarbituric acid (TBA), nitroblue 
tetrazolium chloride (NBT) from Loba Chemie, Mumbai, 
India; 5,5’-dithio bis-2-nitro benzoic acid (DTNB), phena-
zonium methosulphate (PMS), reduced nicotinamide 
adenine dinucleotide (NADH) and reduced glutathione 
(GSH) from SISCO Research Laboratory, Mumbai, India. 
All the other reagents used were of analytical reagent 
grade obtained commercially. Doubled distilled water 
from all-glass still was employed throughout the study.
Preparation of extract (TDA)
The powdered plant material (644  g) was macerated at 
room temperature (24–26  °C) with 20% ethanol water 
(950  mL) for 4 days with occasional shaking, followed 
by re-maceration with the same solvent for 3 days. The 
macerates were combined, filtered and evaporated to dry-
ness in vacuo (at 35 °C and 0.8 MPa) in a Buchi evaporator, 
R-114. The dry extract (TDA, yield: 12.15%) was kept in a 
vacuum dessicator until use. 
Standardization of TDA
TDA was subjected to phytochemical and planar chro-
matographic studies. Qualitative phytochemical analysis 
revealed the presence of reducing sugars, amino acids, 
triterpenoids and steroids in TDA (Harborne, 1998). 
Presence of cucurbitacin type triterpenoid aglycones in 
TDA was ascertained by planar chromatography on silica 
gel pre-coated high performance thin layer chromatogra-
phy (HPTLC) plates (Silica gel 60 F254 Merck, Germany) 
detected with vanillin-phosphoric acid reagent (Wagner 
and Bladt, 1996). TDA was dispersed in isotonic saline 
as per required concentrations and sonicated for 10 min 
immediately prior to administration.
Experimental animals
Adult male Swiss albino mice of about 2 months of age 
weighing 20 ± 2 g were obtained from Laboratory Animal 
Centre, Department of Pharmaceutical Technology, 
Jadavpur University, Kolkata, India. The mice were 
grouped and housed in polyacrylic cages (38 × 23 × 10 cm) 
with not more than four animals per cage and maintained 
under standard laboratory conditions (temperature 
25 ± 2 °C with dark/light cycle 12/12 h). They were allowed 
free access to standard dry pellet diet (Hindustan Lever, 
Kolkata, India) and water ad libitum. The mice were accli-
matized to laboratory conditions for 10 days before com-
mencement of the experiment. All procedures described 
were thoroughly reviewed and approved by the University 
Animal Ethical Committee, Jadavpur University (Reg. no. 
367001/C/CPCSEA).
Preparation of tumor cells
The transplantable murine tumor cell line namely 
Ehrlich ascites carcinoma (EAC) cells were obtained from 
Chittaranjan National Cancer Institute (CNCI), Kolkata, 
India. The EAC cells were maintained in the ascitic form 
in vivo in Swiss mice by means of sequential intraperi-
toneal transplantation of 2 × 106 cells/mouse after every 
10 days. Ascitic fluid was drawn form the EAC bearing 
mouse 8 days after transplantation. The freshly drawn 
fluid was diluted with ice-cold sterile isotonic saline and 
the tumor cell count was adjusted to 2 × 107 cells/mL by 
sterile isotonic saline.
Acute toxicity study
The acute oral toxicity of TDA in male Swiss albino mice 
was studied as per OECD guideline 425 (Anonymous, 
2008). The LD50 value of TDA was determined using the 
method of maximum likelihood.
Eﬀ  ect on normal murine peritoneal cells
The naive mice were divided into three groups (n = 6). The 
first group received TDA at the dose of 50 mg/kg b.w., p.o. 
once for a single day and the second group received the 
same treatment for two consecutive days. The untreated 
third group served as control. Peritoneal exudate cells 
were collected after 24-h treatment by repeated intraperi-
toneal wash with isotonic saline and counted by a hemo-
cytometer in each of the treated group and compared with 
those of the untreated group (Sur & Ganguly, 1994).
Experimental design
The animals were divided into four groups (n = 12). Except 
the first group, all groups received 0.1  ml of EAC cell 
suspension  (2 × 106 cells/mouse, i.p.). This was taken as 
day ‘0’. The first group served as normal saline control 186
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(received isotonic saline, 3 mL/kg body weight, i.p.). The 
second group served as EAC control. After 24 h of tumor 
inoculation the third and fourth group received TDA at 
the doses of 25 and 50 mg/kg body weight, p.o., respec-
tively, for 8 consecutive days. Twenty-four hours after the 
last dose and after 18 h of fasting, blood was collected 
from six mice of each group, by cardiac puncture for the 
estimation of hematological parameters and then sacri-
ficed by cervical dislocation for the study of antitumor 
and hepatic antioxidative parameters. The remaining six 
mice of each group were kept alive with food and water 
ad libitum to assess the increase in the life span of the 
tumor bearing mice. The effect of TDA on tumor prolif-
eration and survival time was assessed by observation of 
tumor volume, tumor weight, packed cell volume, viable 
and non-viable cell count, mean survival time (MST) and 
percentage decrease in life span (% DLS).
Determination of body weight 
The body weight of mice of each group was measured 
immediately before and 8 days after the treatments.
Determination of tumor volume and packed cell volume
The mice were dissected and the ascitic fluid was col-
lected from the peritoneal cavity. The volume of collected 
ascitic fluid was measured by taking it in a graduated cen-
trifuge tube and the packed cell volume was determined 
by centrifuging at 1 000 × g for 5 min. 
Determination of tumor weight
The tumor weight was measured by weighing the mice 
before and after the collection of the ascitic fluid from the 
peritoneal cavity.
Determination of tumor cell count 
The ascitic fluid was taken in a WBC pipette and diluted 
100 times. Then one drop of the diluted suspension was 
placed on the Neubauer counting chamber and the num-
bers of cells in the 64 small squares were counted.
Determination of viability in vitro
The cells were then stained with trypan blue (0.4% in 
isotonic saline) dye (trypan blue dye exclusion assay). The 
cells that did not take up the dye were viable and those 
which took the dye were non-viable. The viable and non-
viable cells were counted.
Determination of survival parameters
The animals were observed for their mortality daily until 
their death or up to a maximum of 40 days. The mortality 
was monitored by recording mean survival time (MST) 
and percentage decrease in life span (% DLS) as per the 
following formula: 
% DLS = 
MST of EAC control group 
MST of TDA treated group
– 1 × 100
*Time denoted by number of days.
Determination of hematological parameters
Collected blood was used for the estimation of hemoglo-
bin (Hb) content, red blood cell (RBC) count and white 
blood cell (WBC) count (D’Armour et al., 1965; Wintrobe 
et al., 1961). Differential count of white blood cells (WBC) 
was carried out from Leishmen stained blood smears 
(Dacie & Lewis, 1958).
Determination of hepatic antioxidative parameters
Lipid peroxidation (TBARS)
The levels of thiobarbituric acid reactive  substances 
(TBARS) in the liver tissue were measured as reported 
(Ohkawa  et al., 1979). The levels of lipid peroxides 
(TBARS) were expressed as μmoles of malondialdehyde 
(MDA)/g of liver tissue.
Reduced glutathione (GSH) and glutathione-S-transferase (GST)
The GSH level of liver tissue was  determined as per 
reported method and expressed as μg/g of liver tissue 
(Ellman, 1959). The enzymatic activity of glutathione-S-
transferase (GST) was measured by the reported method 
and expressed as nanomole of CDNB-GSH conjugate 
formed/min/mg protein (Habig et al., 1974). Total protein 
of liver was estimated for this purpose by the method of 
Lowry et al. (1951). 
Superoxide dismutase (SOD) and catalase (CAT)
The activity of SOD in liver tissue was assayed accord-
ing to the method of Kakkar et al. (1984) and the SOD 
activity was expressed as unit of SOD/mg of liver tissue. 
Catalase activity was assayed according to the method of 
Sinha et al. (1972). The specific activity of catalase (CAT) 
was expressed in terms of μmol of hydrogen peroxide 
decomposed/min/mg of liver tissue. 
Statistical analysis
All data are presented as the mean ± standard error of 
mean (SEM). The results were analyzed for statistical 
significance by one-way analysis of variance (ANOVA) 
followed by Dunnett’s post hoc t e s t  o f  s i g n i f i c a n c e .  
p-values less than 0.05 (p≤0.05) were considered statisti-
cally significant.
Results
Acute toxicity
The oral LD50 value of the hydroalcoholic extract of 
T.  dioica  root (TDA)  in mice was 2  800  mg/kg body 
weight.
Normal peritoneal cell count
The average peritoneal exudate cell count in naïve mice 
was found to be 5.41  ±  0.8  ×  106. Single treatment with 
TDA reduced peritoneal cells to 3.73  ±  1.3  ×  106, while 
two-day consecutive treatment reduced the count to 
2.67 ± 0.8 × 106. Both reductions were found to be signifi-
cant (p<0.001).187
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Body weight
The body weight of mice from EAC control group (after 
8 days) was significantly (p<0.001) increased when 
compared with normal control group. TDA significantly 
(p<0.05) increased the body weights of tumor bearing 
mice in a dose related way as compared to EAC control 
animals (Table 1).
Tumor proliferation and survival parameters
TDA at 25 and 50 mg/kg body weight increased the tumor 
volume, tumor weight, packed cell volume and viable tumor 
cell count significantly (p<0.001) in a dose-dependent 
manner compared to EAC control. Furthermore, TDA 
decreased non-viable tumor cell counts and increased 
viable tumor cell counts significantly (p<0.001) compared 
with the EAC control. In the EAC control group, the mean 
survival time (MST) was 21.42 ± 1.58 days, whereas in TDA 
treated groups the values were 17.93 ± 1.35 (25 mg/kg) and 
12.68 ± 1.12 (50 mg/kg) days, respectively (Table 2).
Hematological parameters
Hematological parameters of tumor bearing mice were 
found to be significantly altered compared to those of 
the normal saline control group. The leukocyte (WBC) 
count was found to be increased and RBC and hemo-
globin decreased in EAC control animals significantly 
(p<0.001) when compared with the normal control group. 
Treatment with TDA at both test doses significantly 
(p<0.001) depleted the hemoglobin content and RBC 
count and elevated the WBC count when compared to 
the EAC control group animals. In differential count 
leukocytes, lymphocytes and monocytes were found to 
be decreased and neutrophils were increased in the EAC 
control group compared with the normal saline treated 
group. TDA treatment significantly (p<0.001) aggravated 
these conditions (Table 3).
Hepatic antioxidative parameters
Lipid peroxidation (TBARS)
The levels of TBARS represented as MDA were sig-
nificantly (p<0.001) increased in EAC control animals 
when compared to the normal control group. Treatment 
with TDA dose dependently and significantly (p<0.001) 
elevated the MDA level in tumor bearing mice compared 
with EAC control animals (Table 4).
Reduced glutathione (GSH) and glutathione-S-transferase (GST)
In the EAC control group, GSH content and GST activ-
ity were found to be significantly (p<0.001) lowered 
compared to those of normal control animals. The level 
of reduced GSH and GST activity were found to be sig-
nificantly (p<0.001) diminished by treatment with TDA 
in tumor bearing mice as compared with EAC control 
group (Table 4).
Superoxide dismutase (SOD) and catalase (CAT)
There were significant (p<0.001) reductions in SOD and 
CAT activities in EAC control group compared with the 
normal saline group. Treatment with TDA significantly 
(p<0.001) lowered their activities when compared with 
the EAC control animals (Table 4).
Discussion
The results of the present study on EAC bearing mice 
revealed that TDA at the doses of 25 and 50 mg/kg wors-
ened the pathologic condition of tumor bearing animals. 
TDA brought about marked proliferation of Ehrlich asci-
tes carcinoma as compared with normally grown trans-
planted tumor, evidenced by a significant rise in body 
weight, tumor volume, tumor weight, packed cell volume, 
viable tumor cell count and decrease in normal peritoneal 
cell count, non-viable tumor cell count, mean survival 
time and life span of tumor bearing animals. TDA signifi-
cantly aggravated the altered hematological parameters. 
TDA also significantly worsened the hepatic antioxidative 
parameters, viz. lipid peroxidation, reduced glutathione 
level (GSH), activities of glutathione-S-transferase (GST), 
superoxide dismutase (SOD) and catalase (CAT) in tumor 
bearing mice.
The effect of TDA treatment on the peritoneal exudate 
cell count of naïve mice is an indirect method of evaluat-
ing its effect on tumor cell growth. Normally a mouse 
contains about 5 × 106 peritoneal cells, 50% of which are 
macrophages. Generally, antitumor agents increase the 
normal peritoneal cell count, thereby inhibiting indirectly 
EAC proliferation (Sur & Ganguly, 1994). TDA treatment 
was found to decrease the peritoneal exudate cell count 
of normal mice. These results demonstrated the indirect 
proliferative effect of TDA on EAC cells, which was prob-
ably mediated by downregulation of either macrophage or 
cytokine systems.
Intraperitoneal inoculation of EAC cells resulted in the 
appearance of ascitic fluid. The ascitic fluid is essential 
for tumor growth since it constitutes a direct nutritional 
source for tumor cells (Gupta et al., 2004). Thus rapid 
increase in ascitic fluid would meet the nutritional 
requirements of growing tumor cells. This hypothesis was 
evident in the present study, since inoculation of EAC cells 
into mice caused significant increase in the body weight of 
EAC bearing mice. The ncrease was due to accumulated 
Table 1. Influence of TDA on body weight of normal and EAC bear-
ing mice.
Treatment
Initial body 
weight (g)
Final body 
weight (g)
Normal saline (3 mL/kg) 21.12±0.78 21.17±1.20
EAC control (2×106cells/mouse) 21.27±0.63 24.74±0.74§a
EAC + TDA (25 mg/kg) 20.65±1.16 26.35±0.58*b
EAC + TDA (50 mg/kg) 21.54±0.86 27.48±1.12*b
Data are expressed as mean ± SEM (n = 6); §final body weight of EAC control 
group vs. normal control group; *final body weight of all treated groups vs. 
EAC control group, ap<0.001, bp<0.05. 188
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ascitic fluid volume in the peritoneal cavity. TDA treat-
ment dose dependently increased the body weight of 
EAC treated mice, indicating enhanced tumor growth.
Cancer is a pathological state involving uncontrolled 
proliferation of tumor cells. The increase in ascitic volume 
was accompanied by an increase in total cell count. This 
is associated with an increase in the peritoneal vascular 
permeability (Fastaia & Dumont, 1976). Treatment with 
TDA increased intraperitoneal tumor burden, thereby 
increasing the tumor volume, tumor weight, packed 
cell volume and viable tumor cell count. The results of 
Trypan blue dye exclusion assay demonstrated that the 
viable cell count increased with a decreased count of 
non-viable cells by TDA treatment. This implied that of 
TDA favorably affected the proliferation of tumor cells, 
leading to multiplication of the TDA treated cells. These 
results could indicate either a direct tumorigenic effect 
of TDA on tumor cells or an indirect effect, which may 
involve macrophage inactivation and vascular perme-
ability enhancement. The results of the present study 
revealed that TDA significantly decreased the life span of 
EAC bearing mice, presumably due to augmented tumor 
progression, indicating its tumorigenic potential in tumor 
bearing mice. 
The general properties of cancer chemotherapeutic 
agents are myelosuppression and anemia (Price and 
Table 2. Influence of TDA on tumor volume, tumor weight, packed cell volume, cell counts, mean survival time (MST) and decrease in life span 
(% DLS) in EAC bearing mice.
Treatment
Tumor Volume 
(mL)
Tumor 
Weight (g)
Packed cell 
Volume (mL)
Viable cell 
count 
(×106 cells /mL)
Non-viable cell 
count
 (×106 cells /mL)
MST 
(days)
Decrease in life 
span (% DLS)
Normal saline 
(3 mL/kg) ––––– A l l  a n i m a l s  a l i v e A l l  a n i m a l s  a l i v e
EAC control (2 ×106cells/
mouse) 3.08±0.35 3.78±0.87 1.85±0.18 6.13±0.13 0.67±0.04 21.42±1.58 –
EAC + TDA (25 mg/kg) 4.89±0.07*a 5.46±0.05*a 2.57±0.06*a 7.61±0.11*a 0.38±0.09*a 17.93±1.35*a 19.46*a
EAC + TDA (50 mg/kg) 6.28±0.27*a 6.91±0.26*a 3.18±0.21*a 9.22±1.07*a 0.24±0.03*a 12.68±1.12*a 68.92*a
Data are expressed as mean ± SEM (n = 6); *all treated groups vs. EAC control group, ap<0.001. 
Table 3. Influence of TDA on hematological parameters of normal and EAC bearing mice.
Treatment
Hb content 
(g/dL)
RBC
(cells ×106/mm3)
WBC
(cells ×103/mm3)
Differential count
Monocytes (%) Neutrophils (%) Lymphocytes (%)
Normal saline 
(3 mL/kg) 12.33±0.15 5.34±0.31 3.36±0.26 1.91±0.06 20.78±1.16 72.46±1.88
EAC control 
(2 ×106cells/mouse) 6.80±0.46§a 3.54±0.17§a 4.26±0.72§a 1.54±0.05§a 58.17±0.98§a 46.28±1.57§a
EAC + TDA 
(25 mg/kg) 4.57±0.18*a 3.06±0.42*b 4.88±0.63*b 1.31±0.04*b 67.72±1.27*a 33.27±2.08*a
EAC + TDA 
(50 mg/kg) 3.46±0.23*a 2.68±0.15*a 5.71±0.12*a 1.12±0.06*a 75.46±1.15*a 25.29±1.96*a
Data are expressed as mean ± SEM (n = 6); §EAC control group vs. normal control group; *all treated groups vs. EAC control group, ap<0.001, 
bp<0.05. 
Table 4. Influence of TDA on hepatic antioxidative parameters of normal and EAC bearing mice.
Treatment
MDA 
(μM/g of wet liver tissue) 
GSH 
(μg/g of wet liver tissue) 
GST 
(nM CDNB-GSH conju-
gate/min/mg of protein 
SOD 
(IU/mg of wet 
liver tissue) 
CAT 
(μM of H2O2 decom-
posed/min/mg of 
wet liver tissue) 
Normal saline 
(3 mL/kg) 167±0.02 29.2±0.23 16.4±0.13 8.7±0.28 38±0.14
EAC control 
(2 ×106cells/mouse) 394±0.03§a 13.2±0.46§a 8.8±0.09§a 6.3±0.63§a 15±0.25§a
EAC + TDA 
(25 mg/kg) 449±0.06*a 8.3±0.19*a 7.2±0.21*b 4.8±0.44*b 12±0.17*b
EAC + TDA 
(50 mg/kg) 482±0.03*a 6.8±0.33*a 5.2±0.17*a 3.6±0.34*a 7±0.30*a
Data are expressed as mean ± SEM (n = 6); §EAC control group vs. normal control group; *all treated groups vs. EAC control group, ap<0.001, 
bp<0.05. 189
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Greenfield, 1958; Hogland, 1982). The anemia encoun-
tered in tumor bearing mice is mainly due to reduction 
in erythrocytes or hemoglobin content, and this may be 
caused by iron deficiency or by hemolytic or myelopathic 
conditions (Gupta et al., 2004b). Results of the present 
study indicated that TDA dose dependently and sig-
nificantly reduced the erythrocyte count and hemoglobin 
content compared to EAC control mice. On the other hand, 
the WBC count was significantly increased compared 
with EAC control mice. These parameters revealed that 
TDA exerted a toxic effect on the hematopoietic system.
The redox state of the cell is known to regulate its 
growth behavior (Pahl and Baeuerle, 1994). The rela-
tionship between the endogenous antioxidant systems 
and growth of malignant cells is a feature observed 
in several studies. Neoplastic growth has been found 
to co-exist with impairment in the endogenous anti-
oxidant status (Oberley, 2002). Low activity of the endog-
enous antioxidant system was found in cancer patients 
(Balasubramaniyan et al., 1994; Casado et al., 1995) and 
in experimental carcinoma cell lines (Yellin et al., 1994; 
Sharma et al., 1993). Considerable evidence suggests that 
EAC induces oxidative stress in mice (Baumgartner et al., 
1978; Gupta et al., 2004a,b; Haldar et al., 2010). Oxidative 
stress is caused by a relative overproduction of oxidative 
free radicals or reactive oxygen species (ROS), resulting 
in lipid peroxidation and subsequently increased malo-
ndialdehyde (MDA) and other TBARS levels, which lead 
to degradation of cellular macromolecules (Yoshikawa 
et al., 1983). Malondialdehyde (MDA), the end product 
of lipid peroxidation, a biomarker of oxidative stress, 
was reported to be higher in carcinomatous tissue than 
in non-diseased organs (Yagi, 1991; Neilson et al., 1997). 
The present study revealed that TBARS levels measured 
as MDA in the EAC control liver tissues were higher than 
those in normal saline treated liver tissues. A marked 
increase in the concentration of TBARS in EAC control 
mice indicated enhanced lipid peroxidation leading to 
tissue injury and failure of the endogenous antioxidant 
defense mechanisms to prevent overproduction of ROS. 
Treatment with TDA enhanced hepatic lipid peroxidation 
as revealed by elevation of the MDA level. This implied 
induction of ROS generation by TDA in tumor bearing 
mice, revealing its pro-oxidant effect. 
Glutathione, the most abundant tripeptide thiol, exists 
as GSH (reduced form) and GSSG (oxidized form) in cells 
and participates in diverse biological processes, includ-
ing detoxification of xenobiotics. Glutathione, a potent 
inhibitor of the neoplastic process, plays an important 
role in the endogenous non-enzymatic antioxidant sys-
tem. In reduced form (GSH), it is found in particularly 
high concentration in the liver and is known to have a 
key function in the protective process. It acts primarily as 
reducing agent and detoxifies hydrogen peroxide (H2O2) 
in the presence of the enzyme glutathione peroxidase 
(Arias & Jakoby, 1976; Meister & Anderson, 1983). Besides 
its involvement in the detoxification process, GSH prob-
ably plays also an important role in lymphocyte function. 
Depletion in GSH content was found to be associated with 
impaired immune response and increased risk of malig-
nancy (Gmunder & Droge, 1991). Lowered glutathione 
content was reported in human cancer cell lines (Yellin 
et al., 1994; Sharma et al., 1993). The depleted reduced 
GSH may be due to reduction in its synthesis or to its 
degradation by oxidative stress in EAC bearing animals. 
TDA treatment significantly lowered the reduced hepatic 
glutathione content in tumor bearing mice. The results 
exhibited that the tumor proliferating activity of TDA 
was accompanied with impairment of the cellular non-
enzymatic antioxidant defense system. 
Glutathione-S-transferases (GSTs) are a family of 
multigene and multifunctional dimeric enzymes that 
catalyze the nucleophilic (conjugation) attack of the 
thiol moiety of glutathione on the electrophilic center 
of various carcinogens, mutagens and other xenobiotic 
compounds (Devi et al., 2002). GSTs play an important 
role in initiating detoxification by catalyzing the conjuga-
tion of GSH to electrophilic foreign compounds for their 
elimination from the system (Mulder et al., 1995). In 
human cancer tissues lower GST activity was reported 
(Yellin et al., 1994; Coursin et al., 1996). Our present study 
revealed a decrease in GST activity in EAC control mice. 
TDA treatment further diminished hepatic GST activity 
significantly in EAC bearing mice. Being attenuated by 
TDA, GSH and GSTs evidently could not act properly to 
prevent tumor progression in EAC bearing mice. 
The enzymatic antioxidant mechanisms are involved 
in the protection of tissues from oxidative stress by 
playing an important role in the elimination of oxidative 
free radicals. Superoxide dismutase (SOD) and catalase 
(CAT) are involved in the clearance of superoxide and 
hydrogen peroxide radicals respectively (Oberley, 2002). 
SOD activity was found to be inhibited in cancer (Jiau-Jian 
& Larry, 1977; Oberley & Oberley, 1997). Both SOD and 
CAT activities were reported to be lower as a result of 
tumor growth (Casado et al., 1995; Marklund et al., 1982). 
Decreased hepatic SOD and CAT activities were found 
also in EAC bearing mice (Gupta et al., 2004b; Haldar 
et al., 2010), and similar findings were observed in our 
present investigation in EAC control mice. The treatment 
with TDA, at either of the doses applied further dimin-
ished the SOD and CAT activities significantly in a dose 
dependent manner. Impairment of enzymatic activities, 
like GSTs, SOD and CAT, in TDA treated tumor bear-
ing mice unveiled attenuation of enzymatic antioxidant 
defense mechanisms, thus aggravating oxidative stress 
and resulting in tumor proliferation in mice. 
Conclusion
The present investigation found that 8-day TDA treat-
ment in tumor bearing mice significantly enhanced 
tumor proliferation and tumor cell viability. It worsened 
the hematological profile and reduced the survival time 
(life span), compared with EAC control mice, i.e. normally 
grown transplanted murine tumor. Further, TDA treat-
ment resulted in significant attenuation of endogenous 190
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antioxidant systems by more than one mechanism, 
involving enhanced lipid peroxidation, impairment of 
endogenous non-enzymatic (GSH) and enzymatic (GST, 
SOD, CAT) antioxidant and detoxification systems. From 
the present investigation it can be therefore concluded 
that the hydroalcoholic extract of T. dioica root induced a 
remarkable tumor promoting effect on Swiss albino mice 
bearing Ehrlich ascites carcinoma, mediated plausibly by 
escalating oxidative stress due to multimodal attenuation 
of endogenous antioxidant defense mechanisms.
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